Familial hematuria

Pediatric Nephrology

Volumn 24, Issue 10, 2009, Pages 1951-1958

  Kashtan, Clifford E ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Alport syndrome; Hematuria; Thin basement membrane nephropathy; Type IV collagen

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; COLLAGEN TYPE 4; COLLAGEN TYPE 4 ALPHA3 CHAIN; COLLAGEN TYPE 4 ALPHA4 CHAIN; COLLAGEN TYPE 4 ALPHA5 CHAIN; CYCLOSPORIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLOMERULUS BASEMENT MEMBRANE ANTIBODY; UNCLASSIFIED DRUG;

ALPORT SYNDROME; AUTOSOMAL DOMINANT INHERITANCE; AUTOSOMAL RECESSIVE INHERITANCE; BLOOD PRESSURE MONITORING; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DRUG POTENTIATION; ELECTRON MICROSCOPY; ENZYME LINKED IMMUNOSORBENT ASSAY; FAMILIAL DISEASE; GENE MUTATION; GENETIC ANALYSIS; GLOMERULONEPHRITIS; HEMATURIA; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MICROSCOPY; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROTEINURIA; REVIEW; SKIN BIOPSY; THIN BASEMENT MEMBRANE NEPHROPATHY; URINALYSIS; X CHROMOSOME LINKED DISORDER;

ADOLESCENT; ANIMALS; CHILD; HEMATURIA; HUMANS; KIDNEY DISEASES;

EID: 70149094317     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-007-0622-z     Document Type: Review

References (38)

1. Lang S, Stevenson B, Risdon RA (1990) Thin basement membrane nephropathy as a cause of recurrent hematuria in childhood. Histopathology 16:331-337
2. Piqueras AI, White RH, Raafat F, Moghal N, Milford DV (1998) Renal biopsy diagnosis in children presenting with hematuria. Pediatr Nephrol 12:386-391
3. Schroder CH, Bontemps CM, Assmann KJ, Schuurmans Stekhoven JH, Foidart JM, Monnens LAH, Veerkamp JH (1990) Renal biopsy and family studies in 65 children with isolated hematuria. Acta Paediatr Scand 79:630-636
4. Trachtman H, Weiss R, Bennett B, Greifer I (1984) Isolated hematuria in children: Indications for a renal biopsy. Kidney Int 25:94-99
5. Seri M, Pecci A, Di Bari F, Cusano R, Savino M, Panza E, Nigro A, Noris P, Gangarossa S, Rocca B, Gresele P, Bizzaro N, Malatesta P, Koivisto PA, Longo I, Musso R, Pecoraro C, Iolascon A, Magrini U, Rodriguez Soriano J, Renieri A, Ghiggeri GM, Ravazzolo R, Balduini CL, Savoia A (2003) MYH9-related disease: May-Hegglin anomaly, Sebastian syndrome, Fechtner syndrome, and Epstein syndrome are not distinct entities but represent a variable expression of a single illness. Medicine (Baltimore) 82:203-215
6. Jais JP, Knebelmann B, Giatras I, De Marchi M, Rizzoni G, Renieri A, Weber M, Gross O, Netzer KO, Flinter F, Pirson Y, Dahan K, Wieslander J, Persson U, Tryggvason K, Martin P, Hertz JM, Schroder C, Sanak M, Carvalho MF, Saus J, Antignac C, Smeets H, Gubler MC (2003) X-linked Alport syndrome: Natural history and genotype-phenotype correlations in girls and women belonging to to 195 families: A "European Community Alport Syndrome Concerted Action" study. J Am Soc Nephrol 14:2603-2610
7. Jais JP, Knebelmann B, Giatras I, De Marchi M, Rizzoni G, Renieri A, Weber M, Gross O, Netzer K-O, Flinter F, Pirson Y, Verellen C, Wieslander J, Persson U, Tryggvason K, Martin P, Hertz JM, Schroder C, Sanak M, Krejcova S, Carvalho MF, Saus J, Antignac C, Smeets H, Gubler MC (2000) X-linked Alport syndrome: Natural history in 195 families and genotype-phenotype correlations in males. J Am Soc Nephrol 11:649-657
8. Jacobs M, Jeffrey B, Kriss A, Taylor D, Sa G, Barratt TM (1992) Ophthalmologic assessment of young patients with Alport syndrome. Ophthalmology 99:1039-1044
9. Rhys C, Snyers B, Pirson Y (1997) Recurrent corneal erosion associated with Alport's syndrome. Kidney Int 52:208-211
10. Colville D, Savige J, Morfis M, Ellis J, Kerr P, Agar J, Fasset R (1997) Ocular manifestations of autosomal recessive Alport syndrome. Ophthalmic Genet 18:119-128
11. Antignac C, Heidet L (1996) Mutations in Alport syndrome associated with diffuse esophageal leiomyomatosis. Contrib Nephrol 117:172-182
12. Zhou J, Mochizuki T, Smeets H, Antignac C, Laurila P, de Paepe A, Tryggvason K, Reeders ST (1993) Deletion of the paired a5(IV) and a6(IV) collagen genes in inherited smooth muscle tumors. Science 261:1167-1169
13. Kashtan CE (2002) Alport syndrome and thin basement membrane disease. Curr Diagnostic Pathol 8:349-360
14. Rumpelt H-J (1980) Hereditary nephropathy (Alport syndrome): Correlation of clinical data with glomerular basement membrane alterations. Clin Nephrol 13:203-207
15. Kashtan CE, Kim Y (1992) Distribution of the a1 and a2 chains of collagen IV and of collagens V and VI in Alport syndrome. Kidney Int 42:115-126
16. Cheong HI, Kashtan CE, Kim Y, Kleppel MM, Michael AF (1994) Immunohistologic studies of type IV collagen in anterior lens capsules of patients with Alport syndrome. Lab Invest 70:553-557
17. Zehnder AF, Adams JC, Santi PA, Kristiansen AG, Wacharasindhu C, Mann S, Kalluri R, Gregory MC, Kashtan CE, Merchant SN (2005) Distribution of type IV collagen in the cochlea in Alport syndrome. Arch Otolaryngol Head Neck Surg 131:1007-1013
18. Nakanishi K, Yoshikawa N, Iijima K, Kitagawa K, Nakamura H, Ito H, Yoshioka K, Kagawa M, Sado Y (1994) Immunohistochemical study of a1-5 chains of type IV collagen in hereditary nephritis. Kidney Int 46:1413-1421
19. van der Loop FT, Monnens LA, Schroder CH, Lemmink HH, Breuning MH, Timmer ED, Smeets HJ (1999) Identification of COL4A5 defects in Alport syndrome by immunochemistry of skin. Kidney Int 55:1217-1224
20. Meleg-Smith S, Magliato S, Cheles M, Garola RE, Kashtan CE (1998) X-linked Alport syndrome in females. Hum Pathol 29:404-408
21. Massella L, Onetti Muda A, Faraggiana T, Bette C, Renieri A, Rizzoni G (2003) Epidermal basement membrane alpha 5(IV) expression in females with Alport syndrome and severity of renal disease. Kidney Int 64:1787-1791
22. Gubler MC, Knebelmann B, Beziau A, Broyer M, Pirson Y, Haddoum F, Kleppel MM, Antignac C (1995) Autosomal recessive Alport syndrome: immunohistochemical study of type IV collagen chain distribution. Kidney Int 47:1142-1147
23. Martin P, Heiskari N, Zhou J, Leinonen A, Tumelius T, Hertz JM, Barker D, Gregory M, Atkin C, Sturkarsdottir U, Neumann H, Springate J, Shows T, Pettersson E, Tryggvason K (1998) High mutation detection rate in the COL4A5 collagen gene in suspected Alport syndrome using PCR and direct DNA sequencing. J Am Soc Nephrol 9:2291-2301
24. Boye E, Mollet G, Forestier L, Cohen-Solal L, Heidet L, Cochat P, Grunfeld J-P, Palcoux J-B, Gubler M-C, Antignac C (1998) Determination of the genomic structure of the COL4A4 gene and of novel mutations causing autosomal recessive Alport syndrome. Am J Hum Genet 63:1329-1340
25. Heidet L, Arrondel C, Forestier L, Cohen-Salal L, Mollet G, Gutierrez B, Stavrou C, Gubler MC, Antignac C (2001) Structure of the human type IV collagen gene COL4A3 and mutations in autosomal Alport syndrome. J Am Soc Nephrol 12:97-106
26. Kashtan CE, McEnery PT, Tejani A, Stablein DM (1995) Renal allograft survival according to primary diagnosis: A report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Nephrol 9:679-684
27. Kashtan CE (2006) Renal transplantation in patients with Alport syndrome. Pediatr Transplant 10:651-657
28. Kashtan CE (2007) Alport syndrome and the X chromosome: Implications of a diagnosis of Alport syndrome in females. Nephrol Dial Transplant 22:1499-1505
29. Browne G, Brown PA, Tomson CR, Fleming S, Allen A, Herriot R, Pusey CD, Rees AJ, Turner AN (2004) Retransplantation in Alport post-transplant anti-GBM disease. Kidney Int 65:675-681
30. Brainwood D, Kashtan C, Gubler MC, Turner AN (1998) Targets of alloantibodies in Alport anti-glomerular basement membrane disease after renal transplantation. Kidney Int 53:762-766
31. Grodecki KM, Gains MJ, Baumal R, Osmond DH, Cotter B, Valli VE, Jacobs RM (1997) Treatment of X-linked hereditary nephritis in Samoyed dogs with angiotensin converting enzyme inhibitor. J Comp Pathol 117:209-225
32. Gross O, Beirowski B, Koepke ML, Kuck J, Reiner M, Addicks K, Smyth N, Schulze-Lohoff E, Weber M (2003) Preemptive ramipril therapy delays renal failure and reduces renal fibrosis in COL4A3-knockout mice with Alport syndrome. Kidney Int 63:438-446
33. Gross O, Koepke ML, Beirowski B, Schulze-Lohoff E, Segerer S, Weber M (2005) Nephroprotection by antifibrotic and anti-inflammatory effects of the vasopeptidase inhibitor AVE7688. Kidney Int 68:456-463
34. Cosgrove D, Kalluri R, Miner JH, Segal Y, Borza DB (2007) Choosing a mouse model to study the molecular pathobiology of Alport glomerulonephritis. Kidney Int 71:615-618
35. Kashtan CE (2005) Familial hematurias: What we know and what we don't. Pediatr Nephrol 20:1027-1035
36. Callis L, Vila A, Carrera M, Nieto J (1999) Long-term effects of cyclosporine A in Alport's syndrome. Kidney Int 55:1051-1056
37. Charbit M, Dechaux M, Gagnadoux M, Grunfeld J, Niaudet P (2003) Cyclosporine A therapy in Alport syndrome. Pediatr Nephrol 22:57-63
38. Kaito H, Nozu K, Iijima K, Nakanishi K, Yoshiya K, Kanda K, Przybyslaw Krol R, Yoshikawa N, Matsuo M (2006) The effect of aldosterone blockade in patients with Alport syndrome. Pediatr Nephrol 21:1824-1829